- Home
- GHRS
GHRS
GH Research PLC
as 11-24-2025 3:30pm EST
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
| Founded: | 2018 | Country: | Ireland |
| Employees: | N/A | City: | N/A |
| Market Cap: | 892.0M | IPO Year: | 2021 |
| Target Price: | $30.11 | AVG Volume (30 days): | 407.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.73 | EPS Growth: | N/A |
| 52 Week Low/High: | $6.72 - $20.50 | Next Earning Date: | 11-06-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest GH Research PLC News
GHRS Breaking Stock News: Dive into GHRS Ticker-Specific Updates for Smart Investing
Market Exclusive
a month ago
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
MT Newswires
a month ago
Needham Initiates GH Research at Buy With $19 Price Target
GlobeNewswire
2 months ago
GH Research Announces Novel Therapies Symposium Presentation and Posters at the 2025 ECNP Congress
Yahoo Finance
2 months ago
Saylor crypto imitators are now under pressure as doubts grow about their business model
Yahoo Finance Video
2 months ago
Trump weighs declaring housing emergency: What the admin. can do
CBS News
2 months ago
3 reasons your grocery bill is getting more expensive
USA TODAY
2 months ago
Disaster preparation has a new wildcard. Will FEMA help?
Reuters
2 months ago
'Canada will take a close look at the Teck-Anglo deal,' finance minister says
Compare GHRS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "GHRS GH Research PLC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.